158 related articles for article (PubMed ID: 18614238)
1. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.
Pavan FR; Poelhsitz GV; Barbosa MI; Leite SR; Batista AA; Ellena J; Sato LS; Franzblau SG; Moreno V; Gambino D; Leite CQ
Eur J Med Chem; 2011 Oct; 46(10):5099-107. PubMed ID: 21875763
[TBL] [Abstract][Full Text] [Related]
3. Antiparasitic activities of novel ruthenium/lapachol complexes.
Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
[TBL] [Abstract][Full Text] [Related]
4. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
[TBL] [Abstract][Full Text] [Related]
5. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes.
Dos Santos ER; Graminha AE; Schultz MS; Correia I; Selistre-de-Araújo HS; Corrêa RS; Ellena J; Lacerda EPS; Pessoa JC; Batista AA
J Inorg Biochem; 2018 May; 182():48-60. PubMed ID: 29433005
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
8. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement.
Rodrigues C; Batista AA; Ellena J; Castellano EE; Benítez D; Cerecetto H; González M; Teixeira LR; Beraldo H
Eur J Med Chem; 2010 Jul; 45(7):2847-53. PubMed ID: 20363536
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
[TBL] [Abstract][Full Text] [Related]
10. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes.
Golfeto CC; Von Poelhsitz G; Selistre-de-Araújo HS; de Araujo MP; Ellena J; Castellano EE; Lopes LG; Moreira IS; Batista AA
J Inorg Biochem; 2010 May; 104(5):489-95. PubMed ID: 20117840
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents.
Pavan FR; Poelhsitz GV; do Nascimento FB; Leite SR; Batista AA; Deflon VM; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 Feb; 45(2):598-601. PubMed ID: 19931948
[TBL] [Abstract][Full Text] [Related]
13. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
14. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
[TBL] [Abstract][Full Text] [Related]
15. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes.
de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709
[TBL] [Abstract][Full Text] [Related]
17. Dinuclear Ru
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
[TBL] [Abstract][Full Text] [Related]
18. Facile ligand oxidation and ring nitration in ruthenium complexes derived from a ligand with dicarboxamide-N and phosphine-P donors.
Fry NL; Rose MJ; Nyitray C; Mascharak PK
Inorg Chem; 2008 Dec; 47(24):11604-10. PubMed ID: 19006289
[TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity.
de Camargo MS; da Silva MM; Correa RS; Vieira SD; Castelli S; D'Anessa I; De Grandis R; Varanda E; Deflon VM; Desideri A; Batista AA
Metallomics; 2016 Feb; 8(2):179-92. PubMed ID: 26758075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
